<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="46753" whole_study_id="46753" phs="002877" v="1" p="1" createDate="2022-04-01T15:56:28-05:00" completedByGPADate="2022-04-06T17:16:15-05:00" modDate="2022-05-26T22:05:29-05:00" maxParentChildStudyModDate="2022-05-26T22:05:29-05:00" handle="TCellStates_DLI" num_participants="17"><StudyInfo accession="phs002877.v1.p1" parentAccession="phs002877.v1.p1"><BioProject id="PRJNA824929" entrez_id="824929" type="bp_admin_access"/><BioProject id="PRJNA824930" entrez_id="824930" type="bp_data_submission"/><StudyNameEntrez>Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy</StudyNameEntrez><StudyTypes2 calculated="No"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="epigen"/><StudyType22 name="cloud_for_sequence"/><StudyType22 name="rnaseq_whole_targ_transcriptome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="dna"/><StudyType22 name="rna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>sra</StudyType></StudyTypes><SraStorages><SraStorage location="Google Cloud"><Person email="davidsentm@mail.nih.gov"><Role>Cloud Service Administrator</Role></Person><Person email="davidsentm@mail.nih.gov"><Role>Data steward</Role></Person></SraStorage></SraStorages></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="CWU001" aid="2" auth="eRA" login="CWU001" fname="Catherine" mname="JU-YING" lname="Wu" email="cwu@partners.org"><Role allow_direct_access="true">PI</Role><Organization>DANA-FARBER CANCER INST</Organization></Person><Person nedid="2000642186" aid="1" auth="cit" login="bourcierkd" fname="Katarzyna" mname="Dorota" lname="Bourcier" email="bourcierkd@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Fanny" lname="Dao" email="fdao@broadinstitute.org"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="2003539324" aid="1" auth="cit" login="kappld" fname="Lee" mname="Daniel" lname="Kapp" email="lee.kapp@nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014159529" aid="1" auth="cit" login="waltont" fname="Tamara" mname="Bene" lname="Walton" email="waltont@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>We thank John Ray, Jaeyoung Chun, Manu Setty, and Daniel Kim for their valuable discussions on ATAC and scRNA-seq profiling and analysis, and Sandhya Prabhakaran for discussions on Symphony. We also thank all members of the Wu and Pe&#8217;er laboratories for helpful discussions and Brian Miller, Tal Nawy, Eva Petschnigg and Mandar Muzumdar for valuable feedback on the manuscript. We appreciate the assistance of Nikolaos Barkas and Peter Kharchenko for preprocessing of inDrop data. Finally, we are grateful for the study nurses and clinical staff that obtained samples, the Pasquarello Tissue Bank in Hematologic Malignancies for processing and banking samples, and the patients who generously consented for the research use of these samples. This work was supported in part by the NCI grants 1R01CA155010 (C.J.W.), P01CA206978 (C.J.W.), U10CA180861 (.C.J.W.), U24CA224331 (C.J.W.), P01CA229092 (R.J.S, J.R, C.J.W), R50CA251956 (S.L.) and U54CA209975 (D.P.); Ludwig Cancer Research (D.P.); The G. Harold and Leila Y. Mathers Foundation (C.J.W) and the Parker Institute for Cancer Immunotherapy (C.J.W, D.P.). P.B. was supported by a Physician-Scientist Training Award from the Damon Runyon Cancer Research Foundation, an Amy Strelzer Manasevit Scholar Award from the Be The Match Foundation, an American Society of Hematology Fellow Scholar Award, and NCI grant 1K08CA248458-01. E.A. was supported by NCI grant K99CA230195 and an American Cancer Society Postdoctoral Fellowship (PF-17-243-01-RMC). C.B. was supported by NCI grant F31CA246901. D.N. was supported by a grant from the NIH (5P30 CA006516). C.J.W. is a Scholar of the Leukemia and Lymphoma Society.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access" gsr_mode_label="Unrestricted access"/><ConsentGroup uid="5147" CGType="cg_class_HMB" title="Health/Medical/Biomedical" name="HMB" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="14" name="completed_by_gpa" title="Completed by GPA"/></Study></dbgapss>